- $2.05bn
- $2.02bn
- $188.63m
Annual income statement for Netlist, fiscal year end - December 27th, USD millions except per share, conversion factor applied.
2022 January 1st | 2022 December 31st | 2023 December 30th | 2024 December 28th | 2025 December 27th | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 142 | 162 | 69.2 | 147 | 189 |
| Cost of Revenue | |||||
| Gross Profit | 48.9 | 11.9 | 2.39 | 2.88 | 11.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 131 | 195 | 131 | 202 | 214 |
| Operating Profit | 11.4 | -33.5 | -61.8 | -55.2 | -25.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 11.5 | -33.4 | -60.4 | -53.9 | -24.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4.83 | -33.4 | -60.4 | -53.9 | -24.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 4.83 | -33.4 | -60.4 | -53.9 | -24.8 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4.83 | -33.4 | -60.4 | -53.9 | -25.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.02 | -0.144 | -0.247 | -0.207 | -0.089 |